Abstract
Background: Gastric cancer (GC) is a malignant tumor with seriously poor outcomes. Studies have shown that microRNAs (miRNAs) play an omnifarious regulatory effect in GC. However, the role of miR-3650 in the progression of GC is not well known.
Methods: In this study, miR-3650 expression and its clinical significance were determined using clinical specimens. The biological functions of miR-3650 were determined in gastric cancer cell lines through CCK-8, cell scratch, and transwell experiments. Bioinformatics predictions, combined with Western blot experiments, were employed to explore its downstream molecular targets.
Results: We observed that miR-3650 was overexpressed in GC specimens and most cell lines, i.e., 77.8% (MKN28, SNU1, AGS, MKN45, N87, BGC823 and SGC7901). The overexpression correlated with advanced T-stage, N-stage, M-stage, and TNM-stage. Furthermore, miR-3650 promoted the proliferation and migration of gastric cancer cells, and its overexpression promoted the PI3K-AKT-mTOR pathway and inhibited the PTEN and hippo pathways. The potassium ion signaling pathway was also involved in the biological process of miR-3650 promoting cancer.
Conclusion: Therefore, we concluded that miR-3650/PTEN/PI3K-AKT-mTOR and miR-3650/hippo pathways are vital in the progression of GC and serve as novel targets for GC therapy.
Graphical Abstract
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[http://dx.doi.org/10.1016/S0140-6736(20)31288-5] [PMID: 32861308]
[http://dx.doi.org/10.3390/ijms21114012] [PMID: 32512697]
[http://dx.doi.org/10.3748/wjg.v22.i8.2403] [PMID: 26937129]
[http://dx.doi.org/10.1111/jgh.15037] [PMID: 32181516]
[http://dx.doi.org/10.1177/1010428317714626] [PMID: 28671042]
[http://dx.doi.org/10.1007/s10555-020-09925-3] [PMID: 32894370]
[http://dx.doi.org/10.1016/j.jaci.2017.08.034] [PMID: 29074454]
[http://dx.doi.org/10.1002/jcp.27486] [PMID: 30471116]
[http://dx.doi.org/10.1038/nsmb.2296] [PMID: 22664986]
[http://dx.doi.org/10.1146/annurev.pathol.4.110807.092222] [PMID: 18817506]
[http://dx.doi.org/10.1016/j.ydbio.2006.08.028] [PMID: 16989803]
[http://dx.doi.org/10.1038/s41580-018-0015-0] [PMID: 29858604]
[http://dx.doi.org/10.1146/annurev.pathol.4.110807.092311] [PMID: 18767981]
[http://dx.doi.org/10.1146/annurev-biochem-013118-111829] [PMID: 30566373]
[http://dx.doi.org/10.1016/j.trecan.2019.04.001] [PMID: 31174842]
[http://dx.doi.org/10.1016/j.canlet.2021.03.006] [PMID: 33737002]
[http://dx.doi.org/10.1038/nrd.2016.246] [PMID: 28209991]
[http://dx.doi.org/10.3390/ijms19123711] [PMID: 30469518]
[http://dx.doi.org/10.3748/wjg.v20.i30.10432] [PMID: 25132759]
[http://dx.doi.org/10.3390/ijms19061683] [PMID: 29882766]
[http://dx.doi.org/10.18632/aging.101981] [PMID: 31163018]
[http://dx.doi.org/10.1007/s12033-022-00491-3] [PMID: 35435592]
[http://dx.doi.org/10.1016/j.prp.2021.153506] [PMID: 34091390]
[http://dx.doi.org/10.7314/APJCP.2014.15.1.17] [PMID: 24528021]
[http://dx.doi.org/10.3892/or.2019.6962] [PMID: 30628706]